Phase 2 and 3 Validation of Protein Biomarkers for the Early Detection of Breast Cancer Discovered Using a Mass Spectrometry-Based Platform

Abbreviated Name
Phase 2 and 3 Validation of Protein Biomarkers for the Early Detection of Breast Cancer Discovered Using a Mas
Lead Investigator
Hanash, SamirThe University of Texas MD Anderson Cancer Center
Coordinating Investigator
Hanash, Samir The University of Texas MD Anderson Cancer Center
Involved Investigators

Abstract

No abstract availalbe.

Aims

No aims available.

Analytic Method

No analytic method available.

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
Start Date
Sep 1 2023
Protocol ID
529
Protocol Type
Single
Fields of Research
  • UNKNOWN
Collaborative Group
Breast and Gynecologic Cancers Research Group
Cancer Types
  • Malignant neoplasm of breast

Associated Forms